{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:09:18Z","timestamp":1761581358007},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","croh-online.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.critrevonc.2015.09.005","type":"journal-article","created":{"date-parts":[[2015,10,21]],"date-time":"2015-10-21T05:05:10Z","timestamp":1445403910000},"page":"322-327","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective"],"prefix":"10.1016","volume":"97","author":[{"given":"Stefano","family":"Arcangeli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Ramella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berardino","family":"De Bari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierfrancesco","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Alongi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolando M.","family":"D\u2019Angelillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.critrevonc.2015.09.005_bib0005","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.ijrobp.2008.02.073","article-title":"Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer","volume":"72","author":"Al-Mamgani","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2015.09.005_bib0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.juro.2009.08.132","article-title":"Impact of positive surgical margins after radical prostatectomy differs by disease risk group","volume":"183","author":"Alkhateeb","year":"2010","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2015.09.005_bib0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.radonc.2009.08.042","article-title":"IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy","volume":"93","author":"Alongi","year":"2009","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2015.09.005_bib0020","doi-asserted-by":"crossref","first-page":"e0118745","DOI":"10.1371\/journal.pone.0118745","article-title":"A Novel MiRNA-Based Predictive model for biochemical failure following post- prostatectomy salvage radiation therapy","volume":"10","author":"Bell","year":"2015","journal-title":"PLoS One"},{"issue":"December 9858","key":"10.1016\/j.critrevonc.2015.09.005_bib0025","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(12)61253-7","article-title":"Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)","volume":"380","author":"Bolla","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2015.09.005_bib0030","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.eururo.2012.04.056","article-title":"Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis","volume":"62","author":"Briganti","year":"2012","journal-title":"Eur. Urol."},{"issue":"suppl; abstr 5006","key":"10.1016\/j.critrevonc.2015.09.005_bib0035","article-title":"Interest of short hormonotherapy (HT) associated with radiotherapy (RT) as salvage treatment for biological relapse (BR) after radical prostatectomy (RP): Results of the GETUG-AFU 16 phase III randomized trial\u2014NCT00423475","volume":"33","author":"Carrie","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2015.09.005_bib0040","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijrobp.2014.05.050","article-title":"18F-Choline Positron Emission Tomography\/ Computed Tomography Driven High-Dose Salvage Radiation Therapy in Patients With Biochemical Progression After Radical Prostatectomy: Feasibility Study in 60 Patients","volume":"90","author":"D\u2019Angelillo","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.critrevonc.2015.09.005_bib0045","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1590\/S0104-11692007000300023","article-title":"The PICO strategy for the research question construction and evidence search","volume":"15","author":"Da Costa Santos","year":"2007","journal-title":"Revista Latino-Americana de Enfermagem."},{"issue":"6","key":"10.1016\/j.critrevonc.2015.09.005_bib0050","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(07)70143-2","article-title":"Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomized controlled trial","volume":"8","author":"Dearnaley","year":"2007","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2015.09.005_bib0055","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.juro.2013.05.053","article-title":"Risk stratification of patients with extraprostatic extension and negative lymph nodes at radical prostatectomy: identifying optimal candidates for adjuvant therapy","volume":"190","author":"Eisenberg","year":"2013","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2015.09.005_bib0060","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1200\/JCO.2014.58.8525","article-title":"Adjuvant and salvage radiotherapy after prostatectomy: American society of clinical oncology clinical practice guideline endorsement","volume":"32","author":"Freedland","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2015.09.005_bib0065","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.juro.2010.08.086","article-title":"Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trial","volume":"185","author":"Hoffman","year":"2011","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2015.09.005_bib0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2490-14-30","article-title":"Concern for overtreatment using the AUA\/ASTRO guideline on adjuvant radiotherapy after radical prostatectomy","volume":"14","author":"Kang","year":"2014","journal-title":"BMC Urol"},{"key":"10.1016\/j.critrevonc.2015.09.005_bib0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijrobp.2007.09.047","article-title":"Improved outcomes with higher doses for salvage radiotherapy after prostatectomy","volume":"71","author":"King","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"March (3)","key":"10.1016\/j.critrevonc.2015.09.005_bib0080","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ijrobp.2011.08.041","article-title":"Adjuvant versus salvage radiotherapy after prostatectomy: the apple versus the orange","volume":"82","author":"King","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2015.09.005_bib0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.semradonc.2013.01.009","article-title":"Adjuvant Versus Salvage Radiotherapyfor High-Risk Prostate Cancer Patients","volume":"23","author":"King","year":"2013","journal-title":"Semin. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2015.09.005_bib0090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijrobp.2007.06.054","article-title":"Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer","volume":"70","author":"Kuban","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2015.09.005_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2008.04.013","article-title":"Adjuvant radiotherapy following radical prostatectomy for pathologic T3 or margin-positive prostate cancer: a systematic review and meta-analysis","volume":"88","author":"Morgan","year":"2008","journal-title":"Radiother. Oncol."},{"issue":"Aug (5)","key":"10.1016\/j.critrevonc.2015.09.005_bib0100","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ijrobp.2010.04.039","article-title":"A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer","volume":"80","author":"Ost","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2015.09.005_bib0105","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/j.1464-410X.2007.06844.x","article-title":"Radiotherapy and androgen deprivationin combination after local surgery (RADICALS): a new Medical Research Council\/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomy","volume":"99","author":"Parker","year":"2007","journal-title":"BJU Int."},{"key":"10.1016\/j.critrevonc.2015.09.005_bib0110","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.eururo.2013.08.013","article-title":"Early salvage radiotherapy following radical prostatectomy","volume":"65","author":"Pfister","year":"2014","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2015.09.005_bib0115","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.canrad.2010.07.224","article-title":"Postoperative radiotherapy of prostate cancer (GETUG-17)","volume":"14","author":"Richaud","year":"2010","journal-title":"Cancer Radiother."},{"issue":"Suppl. (3)","key":"10.1016\/j.critrevonc.2015.09.005_bib0120","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.ijrobp.2010.07.103","volume":"78","author":"Shipley","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2015.09.005_bib0125","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1200\/JCO.2006.08.9607","article-title":"Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy","volume":"25","author":"Stephenson","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2015.09.005_bib0130","first-page":"0","article-title":"The promise of comparative effectiveness research","volume":"40","author":"Sullivan","year":"2011","journal-title":"JAMA 305(4)"},{"key":"10.1016\/j.critrevonc.2015.09.005_bib0135","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.juro.2008.11.032","article-title":"Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term follow up of a randomized clinical trial","volume":"181","author":"Thompson","year":"2009","journal-title":"J. Urol."},{"issue":"December (6)","key":"10.1016\/j.critrevonc.2015.09.005_bib0140","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.urology.2008.05.057","article-title":"A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer","volume":"72","author":"Trabulsi","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.critrevonc.2015.09.005_bib0145","unstructured":"Trans-Tasman Radiation Oncology Group: (Trog 08-03) RAVES trial:Radiotherapy\u2014Adjuvant versus early salvage."},{"key":"10.1016\/j.critrevonc.2015.09.005_bib0150","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ijrobp.2013.05.029","article-title":"Adjuvant and salvage radiation therapy afterprostatectomy: American society for radiation oncology\/american urological association guidelines","volume":"86","author":"Valicenti","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"August (2)","key":"10.1016\/j.critrevonc.2015.09.005_bib0155","first-page":"193","article-title":"Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02\/AUO AP 09\/95 trial","volume":"64","author":"Wiegel","year":"2013","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2015.09.005_bib0160","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cct.2012.09.008","article-title":"Competing event risk stratification may improve the design and efficiency of clinical trials: secondary analysis of SWOG 8794","volume":"34","author":"Zakeri","year":"2013","journal-title":"Contemp. Clin. Trials"},{"issue":"7","key":"10.1016\/j.critrevonc.2015.09.005_bib0165","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1200\/JCO.2009.25.8475","article-title":"Randomized trial comparing conventional dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group\/American College of Radiology 95\u201309","volume":"28","author":"Zietman","year":"2010","journal-title":"J. Clin. Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842815300457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842815300457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T15:20:06Z","timestamp":1537284006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842815300457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":33,"alternative-id":["S1040842815300457"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2015.09.005","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2015.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}